Guided Therapeutics (GTHP) Asset Writedowns and Impairment (2016 - 2025)
Guided Therapeutics (GTHP) reported Asset Writedowns and Impairment of $30000.0 for Q4 2025, up 314.29% on a YoY basis from $7241.4 in Q4 2024, and up 1400.0% sequentially from $2000.0 in Q3 2025.
Guided Therapeutics (GTHP) Asset Writedowns and Impairment (2016 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 6 years of Asset Writedowns and Impairment data on file, last reported at $30000.0 in Q4 2025.
- For the quarter ending Q4 2025, Asset Writedowns and Impairment rose 314.29% year-over-year to $30000.0; the trailing twelve-month figure through Dec 2025 stood at $26000.0 (up 128.26% YoY), and the FY2025 full-year result was $33000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment grew to $30000.0 in Q4 2025, from $2000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $30000.0 in Q4 2025 to a low of -$14000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Dec 31, 2024 | -14,000.00 |
| Dec 31, 2024 | -14,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Dec 31, 2020 | -86,000.00 |
| Dec 31, 2020 | -86,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Dec 31, 2017 | -124,000.00 |
| Dec 31, 2017 | -124,000.00 |
| Sep 30, 2017 | 333,000.00 |
| Sep 30, 2017 | 333,000.00 |
| Mar 31, 2017 | -35,000.00 |
| Mar 31, 2017 | -35,000.00 |
| Dec 31, 2016 | 217,000.00 |
| Dec 31, 2016 | 217,000.00 |